Capgemini is in a market-leading or near-dominating position in key markets. Click here to read more about CGEMY stock and why it is rated as a Buy.

Discover HSIC's growth potential with strong Q1 earnings, bullish trends, revamped sales strategies, and ongoing buybacks.

Q1 2025 Earnings Call Transcript May 15, 2025 Worksport Ltd. reports earnings inline with expectations. Reported EPS is ...

Q1 2025 Earnings Call Transcript May 15, 2025 Fluent, Inc. beats earnings expectations. Reported EPS is $-0.31, expectations ...

Cleveland Clinic reported an operating income of $52.8 million (1.3% margin) in the first quarter, up slightly from $50.2 million (1.3% margin) in the same period last year, according to financial ...

CGT unionists and employees participate in a rally outside ArcelorMittal headquarters to put ... More pressure on the French ...

Angel One, once a top beneficiary of India's retail investing boom, is now facing headwinds due to tighter SEBI regulations ...

McKesson Corporation announced its intention to separate its Medical-Surgical Solutions segment into an independent company.

Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, ...

Management targets JPY 65 billion-JPY 75 billion in capital expenditure per year over the medium term. We think its operating cash flow could support such a level of investments, but the dividend ...

Cheltenham-headquartered Spirax Group has said it maintains its outlook for 2025 while recognising that the evolving broader ...

First quarter 2025 GAAP operating expense was $11.4 million, a decrease of 66% compared to $33.9 million in the first quarter of 2024. The year-over-year decrease was primarily due to a decrease in ...